Tonix Pharmaceuticals Holding Corp.

DB:TPM0 Stock Report

Market Cap: €11.8m

Tonix Pharmaceuticals Holding Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of TPM0?
Owner TypeNumber of SharesOwnership Percentage
Public Companies10.00000752%
Private Companies40.0000301%
Individual Insiders4,5480.0342%
Institutions1,248,7959.39%
General Public12,038,99390.6%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 131.7%.


Top Shareholders

Top 25 shareholders own 9.43% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
2.92%
The Vanguard Group, Inc.
388,444€344.2k149%no data
1.47%
Renaissance Technologies LLC
195,587€173.3k1.18%no data
1.32%
Tang Capital Management, LLC
176,067€156.0k-75.6%0.02%
0.86%
Morgan Stanley & Co. International Plc Investment Account
113,914€100.9k231%no data
0.64%
Geode Capital Management, LLC
85,361€75.6k43.5%no data
0.36%
BlackRock, Inc.
48,297€42.8k-0.19%no data
0.36%
Azimut Capital Management Sgr SpA
48,000€42.5k0%no data
0.35%
JPMorgan Chase & Co, Brokerage and Securities Investments
46,885€41.5k490%no data
0.33%
Raymond James Financial Inc., Asset Management Arm
44,364€39.3k4.17%no data
0.23%
State Street Global Advisors, Inc.
31,204€27.6k310%no data
0.19%
Acadian Asset Management LLC
25,655€22.7k-82.2%no data
0.12%
Northern Trust Global Investments
16,301€14.4k102%no data
0.072%
Two Sigma Investments, LP
9,630€8.5k184%no data
0.046%
Wilcoxson Wealth Management
6,137€5.4k0.52%no data
0.031%
UBS Asset Management AG
4,127€3.7k-61.8%no data
0.029%
Two Sigma Securities, LLC, Asset Management Arm
3,888€3.4k-56.2%no data
0.029%
Seth Lederman
3,799€3.4k-14.4%no data
0.014%
Impact S.P.A. Societa Di Intermediazione Mobiliare O In Forma Abbreviata Impact Sim S.P.A.
1,848€1.6k0%no data
0.011%
Edmond de Rothschild Asset Management (France)
1,500€1.3k0%no data
0.0082%
Victory Capital Management Inc.
1,090€965.70%no data
0.007%
Securities America Advisors, Inc.
929€823.2167%no data
0.0037%
Gregory Sullivan
496€439.30%no data
0.0012%
PNC Financial Services Group Inc., Banking Investments
160€141.30%no data
0.001%
NVWM LLC
139€123.70%no data
0.00088%
Federated Hermes, Inc.
117€103.6-19.3%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/08/06 13:36
End of Day Share Price 2023/05/09 00:00
Earnings2023/03/31
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Tonix Pharmaceuticals Holding Corp. is covered by 10 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
James MolloyAlliance Global Partners
David BuckB. Riley Securities, Inc.
Kumaraguru RajaBrookline Capital Markets